We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXC icon
351
Exelon
EXC
$47B
$34.6M 0.05%
1,012,939
-14,291
-1% -$504K
VXUS icon
352
Vanguard Total International Stock ETF
VXUS
$160B
$34.6M 0.05%
656,248
+11,870
+2% +$620K
MCK icon
353
McKesson
MCK
$101B
$34.6M 0.05%
257,195
-3,694
-1% -$461K
LVS icon
354
Las Vegas Sands
LVS
$29.6B
$34.4M 0.05%
582,945
+29,929
+5% +$1.85M
ISRG icon
355
Intuitive Surgical
ISRG
$134B
$34.4M 0.05%
196,767
-5,748
-3% -$985K
VMBS icon
356
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
$34.2M 0.05%
648,087
+34,591
+6% +$1.81M
XYZ
357
Block Inc
XYZ
$47.5B
$34.2M 0.05%
471,378
-89,484
-16% -$6.25M
CONE
358
DELISTED
CyrusOne Inc Common Stock
CONE
$34.2M 0.05%
592,041
-40,760
-6% -$2.39M
IHI icon
359
iShares US Medical Devices ETF
IHI
$3.38B
$34.2M 0.05%
851,724
+34,530
+4% +$1.31M
GS icon
360
Goldman Sachs
GS
$303B
$34.1M 0.05%
166,783
-39,505
-19% -$7.82M
STEW
361
SRH Total Return Fund
STEW
$1.81B
$34.1M 0.05%
3,034,886
-551,107
-15% -$6.05M
RSPT icon
362
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.87B
$34M 0.05%
1,914,380
-139,830
-7% -$2.42M
LBRDK icon
363
Liberty Broadband Class C
LBRDK
$5.15B
$34M 0.05%
325,797
+10,835
+3% +$1.07M
AZPN
364
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$33.9M 0.05%
272,612
+38,289
+16% +$4.76M
NLSN
365
DELISTED
Nielsen Holdings plc
NLSN
$33.8M 0.05%
1,494,679
-411,621
-22% -$9.95M
STZ icon
366
Constellation Brands
STZ
$23.2B
$33.7M 0.05%
171,085
+5,897
+4% +$1.15M
SNA icon
367
Snap-on
SNA
$21.5B
$33.6M 0.05%
202,837
+8,361
+4% +$1.36M
FE icon
368
FirstEnergy
FE
$27.5B
$33.6M 0.05%
783,729
+8,260
+1% +$347K
CDW icon
369
CDW
CDW
$17B
$33.5M 0.05%
301,378
+18,411
+7% +$1.93M
GM icon
370
General Motors
GM
$76.8B
$33.4M 0.05%
867,280
+12,935
+2% +$485K
ASML icon
371
ASML
ASML
$669B
$33.2M 0.05%
159,897
+8,039
+5% +$1.6M
LM
372
DELISTED
Legg Mason, Inc.
LM
$33.2M 0.05%
867,857
-40,381
-4% -$1.4M
DGRO icon
373
iShares Core Dividend Growth ETF
DGRO
$43.5B
$32.9M 0.05%
861,634
+94,598
+12% +$3.55M
WP
374
DELISTED
Worldpay, Inc.
WP
$32.9M 0.05%
268,186
-13,889
-5% -$1.65M
YUMC icon
375
Yum China
YUMC
$16.3B
$32.7M 0.05%
708,017
-233,759
-25% -$10.1M

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.